Wall Street fecha semana sem rumo. Grandes tecnológicas pressionam

[Info]

Como diz o Ulisses é sempre um perigo shortar qq biotech.. mas aqui fica uma nota dos lamirés dos da Morgan:

"Morgan Stanley downgrades biotech group :

Morgan Stanley downgrades the biotech sector to In-Line from Attractive, as the majority of co's are at or near their price targets and firm believes that it is time to take some money off the table.
In addition, forward growth rates are slowing as YoY comps become more difficult (potentially putting pressure on multiples), while the next 12 months P/E ratios are at a 68% premium to S&P 500 and 88% premium to large-cap pharma."

Cump.